PubMed

Comparison of rosuvastatin and atorvastatin for lipid lowering in patients with type 2 diabetes mellitus: results from the URANUS study.

Berne C, Siewert-Delle A; URANUS study investigators.

Cardiovasc Diabetol. 2005 Jun 3;4:7.PMID: 15935095 [PubMed]Related articlesFree article

Effects of rosuvastatin and atorvastatin compared over 52 weeks of treatment in patients with hypercholesterolemia.

Olsson AG, Istad H, Luurila O, Ose L, Stender S, Tuomilehto J, Wiklund O, Southworth H, Pears J, Wilpshaar JW; Rosuvastatin Investigators Group.

Am Heart J. 2002 Dec;144(6):1044-51.PMID: 12486429 [PubMed - indexed for MEDLINE]Related articles

Comparison of the efficacy and safety of rosuvastatin 10 mg and atorvastatin 20 mg in high-risk patients with hypercholesterolemia--Prospective study to evaluate the Use of Low doses of the Statins Atorvastatin and Rosuvastatin (PULSAR).

Clearfield MB, Amerena J, Bassand JP, Hernández García HR, Miller SS, Sosef FF, Palmer MK, Bryzinski BS.

Trials. 2006 Dec 21;7:35.PMID: 17184550 [PubMed]Related articlesFree article

A randomised study comparing the efficacy and safety of rosuvastatin with atorvastatin for achieving lipid goals in clinical practice in Asian patients at high risk of cardiovascular disease (DISCOVERY-Asia study).

Zhu JR, Tomlinson B, Ro YM, Sim KH, Lee YT, Sriratanasathavorn C.

Curr Med Res Opin. 2007 Dec;23(12):3055-68.PMID: 18196620 [PubMed - indexed for MEDLINE]Related articles

Comparison of the effects of policosanol and atorvastatin on lipid profile and platelet aggregation in patients with dyslipidaemia and type 2 diabetes mellitus.

Castaño G, Fernández L, Mas R, Illnait J, Mesa M, Fernández JC.

Clin Drug Investig. 2003;23(10):639-50.PMID: 17535079 [PubMed - in process]Related articles

The DISCOVERY PENTA study: a DIrect Statin COmparison of LDL-C Value--an Evaluation of Rosuvastatin therapY compared with atorvastatin.

Fonseca FA, Ruiz A, Cardona-Muñoz EG, Silva JM, Fuenmayor N, Marotti M; DISCOVERY PENTA investigators.

Curr Med Res Opin. 2005 Aug;21(8):1307-15.PMID: 16083541 [PubMed - indexed for MEDLINE]Related articles

Effects of rosuvastatin on lipids, lipoproteins and apolipoproteins in the dyslipidaemia of diabetes.

Betteridge DJ, Gibson JM.

Diabet Med. 2007 May;24(5):541-9. Epub 2007 Mar 15.PMID: 17367312 [PubMed - indexed for MEDLINE]Related articles

Achieving low-density lipoprotein cholesterol goals in high-risk patients in managed care: comparison of rosuvastatin, atorvastatin, and simvastatin in the SOLAR trial.

Insull W Jr, Ghali JK, Hassman DR, Y As JW, Gandhi SK, Miller E; SOLAR Study Group.

Mayo Clin Proc. 2007 May;82(5):543-50. Erratum in: Mayo Clin Proc. 2007 Jul;82(7):890. PMID: 17493418 [PubMed - indexed for MEDLINE]Related articlesFree article

A review of the efficacy of rosuvastatin in patients with type 2 diabetes.

Tuomilehto J, Leiter LA, Kallend D.

Int J Clin Pract Suppl. 2004 Oct;(143):30-40. Review.PMID: 16035394 [PubMed - indexed for MEDLINE]Related articles

Effects of low-dose atorvastatin and rosuvastatin on plasma lipid profiles: a long-term, randomized, open-label study in patients with primary hypercholesterolemia.

Mazza F, Stefanutti C, Di Giacomo S, Vivenzio A, Fraone N, Mazzarella B, Bucci A.

Am J Cardiovasc Drugs. 2008;8(4):265-70.PMID: 18690760 [PubMed - indexed for MEDLINE]Related articles

A comparative study with rosuvastatin in subjects with metabolic syndrome: results of the COMETS study.

Stalenhoef AF, Ballantyne CM, Sarti C, Murin J, Tonstad S, Rose H, Wilpshaar W.

Eur Heart J. 2005 Dec;26(24):2664-72. Epub 2005 Sep 5.PMID: 16143705 [PubMed - indexed for MEDLINE]Related articlesFree article

Rosuvastatin is cost-effective compared with atorvastatin in reaching cholesterol goals.

Hirsch M, O'donnell J, Olsson A.

Int J Cardiol. 2005 Oct 10;104(3):251-6.PMID: 16186052 [PubMed - indexed for MEDLINE]Related articles

LDL-C/HDL-C ratio in subjects with cardiovascular disease and a low HDL-C: results of the RADAR (Rosuvastatin and Atorvastatin in different Dosages And Reverse cholesterol transport) study.

Jukema JW, Liem AH, Dunselman PH, van der Sloot JA, Lok DJ, Zwinderman AH.

Curr Med Res Opin. 2005 Nov;21(11):1865-74.PMID: 16307708 [PubMed - indexed for MEDLINE]Related articles

Comparison of rosuvastatin with atorvastatin, simvastatin and pravastatin in achieving cholesterol goals and improving plasma lipids in hypercholesterolaemic patients with or without the metabolic syndrome in the MERCURY I trial.

Stender S, Schuster H, Barter P, Watkins C, Kallend D; MERCURY I Study Group.

Diabetes Obes Metab. 2005 Jul;7(4):430-8. Erratum in: Diabetes Obes Metab. 2005 Jul;7(4):460. PMID: 15955130 [PubMed - indexed for MEDLINE]Related articles

Efficacy and safety of rosuvastatin 40 mg versus atorvastatin 80 mg in high-risk patients with hypercholesterolemia: results of the POLARIS study.

Leiter LA, Rosenson RS, Stein E, Reckless JP, Schulte KL, Schleman M, Miller P, Palmer M, Sosef F; POLARIS study investigators.

Atherosclerosis. 2007 Oct;194(2):e154-64. Epub 2007 Jan 16.PMID: 17229426 [PubMed - indexed for MEDLINE]Related articles

Titration patterns with rosuvastatin as compared with other statins in clinical practice: a retrospective observational cohort study using an electronic medical record database.

Fox KM, Gandhi SK, Ohsfeldt RL, Blasetto JW, Davidson MH.

Clin Ther. 2007 Nov;29(11):2385-94.PMID: 18158079 [PubMed - indexed for MEDLINE]Related articles

[Compared with atorvastatin at the dose of 10 mg per day rosuvastatin was more effective to reach an LDL goal of < 1.00 g/l in high cardiovascular risk patients (ARIANE study)]

Danchin N, Chadarevian R, Gayet JL, Licour M, Valensi P.

Ann Cardiol Angeiol (Paris). 2007 Apr;56(2):82-7. French. PMID: 17484092 [PubMed - indexed for MEDLINE]Related articles

Efficacy and tolerability of rosuvastatin and atorvastatin when force-titrated in patients with primary hypercholesterolemia: results from the ECLIPSE study.

Faergeman O, Hill L, Windler E, Wiklund O, Asmar R, Duffield E, Sosef F; ECLIPSE Study Investigators.

Cardiology. 2008;111(4):219-28. Epub 2008 Apr 23.PMID: 18434729 [PubMed - indexed for MEDLINE]Related articles

Achieving LDL cholesterol, non-HDL cholesterol, and apolipoprotein B target levels in high-risk patients: Measuring Effective Reductions in Cholesterol Using Rosuvastatin therapY (MERCURY) II.

Ballantyne CM, Bertolami M, Hernandez Garcia HR, Nul D, Stein EA, Theroux P, Weiss R, Cain VA, Raichlen JS.

Am Heart J. 2006 May;151(5):975.e1-9.PMID: 16644314 [PubMed - indexed for MEDLINE]Related articles

Low-density lipoprotein cholesterol (LDL-C) levels and LDL-C goal attainment among elderly patients treated with rosuvastatin compared with other statins in routine clinical practice.

Harley CR, Gandhi S, Blasetto J, Heien H, Sasane R, Nelson SP.

Am J Geriatr Pharmacother. 2007 Sep;5(3):185-94.PMID: 17996658 [PubMed - indexed for MEDLINE]Related articles